• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenith Health Care Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5117.0
  • ISIN : INE812B01026
3.89 0 (-3.47%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    3.80

  • Today’s High

    4.09

  • Open

    4.09

  • Perv Close

    4.03

  • 52W Low

    3.80

  • 52W High

    6.87

Key Indicators

  • P/E(TTM)

    389.00

  • Mar.Cap (₹Cr.)

    20.90

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.38

  • Debt-Equity Ratio

    -3.47

  • AGM Date

    01-Aug-2025

  • EPS

    0.01

  • P/E Ratio

    389.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    20.90

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.37

  • BV (₹)

    1.40

  • Sales( ₹ in Cr.)

    11.33

  • NP (in Cr.)

    0.07

  • NP Var(%)

    -67.0

  • Div%

    0.0

  • CPS (₹)

    0.10

  • EPS (₹)

    0.00

  • Traded Value (₹ in Lakhs)

    20.90

  • 52 Week High

    6.87

  • 52 Week Low

    3.80

  • Price BSE

    4.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    20.90

  • P/C Ratio

    71.80

  • P/E Ratio

    320.80

  • Price Vs.BV

    0.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 14.47 13.13 22.36 13.74 11.98 9.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 14.47 13.13 22.36 13.74 11.98 9.83
Other Income 0.27 0.38 0.52 0.46 0.30 0.21
Stock Adjustments -0.84 -0.41 0.23 1.14 -0.43 0.55
Total Income 13.90 13.10 23.11 15.34 11.85 10.59
EXPENDITURE :            
Raw Materials 7.08 7.66 12.84 9.34 6.93 7.22
Power and Fuel Cost 0.07 0.06 0.06 0.07 0.16 0.15
Employee Cost 1.40 1.28 1.37 1.05 0.94 0.85
Other Manufacturing Expenses 0.75 0.27 0.27 0.23 0.47 0.24
Selling and Administration Expenses 3.51 3.02 7.57 3.82 2.24 1.56
Miscellaneous Expenses 0.59 0.39 0.03 0.00 0.25 0.15
Employee Benefit Expenses 1.40 1.28 1.37 1.05 0.94 0.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 13.40 12.69 22.14 14.52 11.00 10.17
Operating Profit 0.50 0.41 0.97 0.82 0.85 0.41
Interest 0.01 0.01 0.01 0.01 0.01 0.00
Gross Profit 0.49 0.40 0.96 0.81 0.84 0.41
Depreciation 0.21 0.28 0.36 0.25 0.25 0.25
Profit Before Tax 0.28 0.12 0.60 0.56 0.59 0.16
Current Tax 0.07 0.03 0.18 0.13 0.02 0.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.01 0.11 -0.02 0.00 0.00
Reported Net Profit 0.20 0.08 0.31 0.44 0.57 0.14
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.20 0.08 0.31 0.44 0.57 0.14
Adjustment below Net Profit -0.10 0.00 0.00 0.00 0.04 0.00
P & L Balance brought forward 1.84 1.76 1.45 1.01 0.41 0.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 1.95 1.84 1.76 1.45 1.01 0.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.04 0.01 0.06 0.08 0.11 0.03
Earnings Per Share(Adj)-Unit Curr 0.04 0.01 0.06 0.08 0.11 0.03
Book Value 1.37 1.35 1.33 1.27 1.19 1.08
Book Value(Adj)-Unit Curr 1.37 1.35 1.33 1.27 1.19 1.08

Shareholding Pattern

  • Promoter Group

    28.74%

  • Public Share Holding

    71.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,252,550 4.19 2,252,550 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 13,191,029 24.55 13,001,529 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,443,579 28.74 15,254,079 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 211,000 0.39 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 211,000 0.39 0 1
2] Non Institution
Bodies Corporate 2,492,954 4.64 1,871,454 28
Clearing Members 50,496 0.09 50,496 9
Directors of their Relatives 0 0.00 0 0
Employees 13,500 0.03 0 15
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 719,679 1.34 544,679 139
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 357,183 0.66 357,183 117
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,355,913 6.24 721,413 7
Individuals holding nominal share capital up to Rs. 1 lakh 31,094,696 57.86 23,036,696 40,811
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 38,084,421 70.87 26,581,921 41,126
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 53,739,000 100.00 41,836,000 41,137

Company Background

Zenith Health Care LtdPharmaceuticals - Indian - Formulations

  • Zenith Health Care Ltd
  • BSE Code : 5117.0
  • ISIN : INE812B01026

  • Incorporation Year

    1994

  • Registered Office

    504 Iscon Elegance S G Road
    Nr Ananddham Jain Derasar, Ahmedabad,
    Gujarat-380051

  • Telephone

    91-79-66168889/66168890

  • FAX

    91-79-66168891

  • Chairman

    Mahendra C Raycha

  • Managing Director

    Mahendra C Raycha

  • Company Secretary

    Mihir Satishkumar Shah

  • Auditor

    A R Pandhi & associates/Doshi Doshi & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Big Share Services Pvt Ltd
    E-2/3 Saki Vihar Rd ,
    Ansa Indl Estate ,Saki Naka Andheri-E
    Mumbai - Mumbai - 400 072

Zenith Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenith Health 3.89 14.74 14.47 389.00 3.85
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10